GlobalAccess Eurp ex-UK Alpha Z Acc EUR |
Performance History | 30/04/2024 |
Growth of 1,000 (EUR) |
Fund | 4.5 | 24.1 | -16.8 | 15.7 | 4.4 | |
+/-Cat | 1.0 | 1.1 | -3.2 | -0.5 | -1.7 | |
+/-Idx | 2.4 | -0.9 | -4.4 | -2.0 | -1.9 | |
Category: Europe ex-UK Equity | ||||||
Benchmarks: Morningstar DM Eur xUK TME ... |
Key Stats | ||
NAV 16/05/2024 | EUR 3.21 | |
Day Change | -0.40% | |
Morningstar Category™ | Europe ex-UK Equity | |
ISIN | IE00B29M3G77 | |
Fund Size (Mil) 30/04/2024 | EUR 100.06 | |
Share Class Size (Mil) 30/04/2024 | EUR 11.98 | |
Max Initial Charge | 5.00% | |
Ongoing Charge 15/02/2024 | 2.43% |
Investment Objective: GlobalAccess Eurp ex-UK Alpha Z Acc EUR |
The Fund seeks superior long-term capital growth primarily through investment in companies of European Countries, excluding the UK. The Fund is actively managed. The Fund invests primarily in common stock, preferred shares and securities convertible into common stock, of established companies domiciled or having significant operations (and listed or traded on a Regulated Market) in a range of European Countries, excluding the UK. |
Returns | |||||||||||||
|
Management | ||
Manager Name Start Date | ||
Ian Aylward 01/03/2019 | ||
Inception Date 30/04/2008 |
Advertisement |
Benchmarks | |
Fund Benchmark | Morningstar Benchmark |
MSCI Europe Ex UK NR USD | Morningstar DM Eur xUK TME NR EUR |
Target Market | ||||||||||||||||||||
|
Portfolio Profile for GlobalAccess Eurp ex-UK Alpha Z Acc EUR | 30/04/2024 |
|
|
Top 5 Holdings | Sector | % |
Novo Nordisk A/S Class B | Healthcare | 3.74 |
ASML Holding NV | Technology | 3.00 |
Lvmh Moet Hennessy Louis Vuitton SE | Consumer Cyclical | 2.58 |
UniCredit SpA | Financial Services | 2.30 |
Sanofi SA | Healthcare | 2.28 |
Increase Decrease New since last portfolio | ||
GlobalAccess Eurp ex-UK Alpha Z Acc EUR |